20th February 2025

Management of drug-induced ILD

Management is focused on withdrawal of the causative medication. If disease persists or continues to progress, steroids might be helpful in some patterns of disease.

See note on nintedanib – this has now been approved as a treatment option for chronic progressive fibrosing interstitial lung diseases.